ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: pediatric rheumatology

Pinpoint Cognitive Dysfunction in Patients with Lupus

  |  

More than 80% of SLE patients experience some type of neurologic manifestation during their disease course. The challenge for rheumatologists and other clinicians lies in appropriately diagnosing any cognitive dysfunctions that accompany lupus and better understanding the causes and risk factors of those dysfunctions. “Cognitive Function in SLE” was the focus of a talk at the 2011 ACR/ARHP Annual Scientific Meeting in November.

The Mystery of IVIg

Eveline Wu, MD, Michael M. Frank, MD  |  

Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.

ACR Participates in Briefing to Highlight Importance of Biomedical Research

  |  

On September 13, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Coalition held a congressional briefing to commemorate the 25th anniversary of the organization’s honoring of congressional champions who have been instrumental in supporting NIAMS and the NIH. The Coalition is a group of more than 70 medical, patient-advocacy, and science-based organizations (including the ACR) dedicated to advancing the critical research of the NIAMS and the NIH. The Coalition’s mission is to elevate understanding of the value of the NIAMS among policy makers and the public to foster increased support of the Institute.